The level of cerebrospinal fluid tau correlates with neurofibrillary tangles in Alzheimer's disease

被引:123
作者
Tapiola, T
Overmyer, M
Lehtovirta, M
Helisalmi, S
Ramberg, J
Alafuzoff, I
Riekkinen, P
Soininen, H
机构
[1] Kuopio Univ Hosp, Dept Neurol & Neurosci, FIN-70211 Kuopio, Finland
[2] Kuopio Univ Hosp, AI Virtanen Inst, FIN-70211 Kuopio, Finland
[3] Kuopio Univ Hosp, Dept Obstet & Gynecol, Clin Genet Unit, FIN-70211 Kuopio, Finland
[4] Univ Kuopio, FIN-70211 Kuopio, Finland
[5] Orion Diagnost, Oulunsalo, Finland
关键词
Alzheimer's disease; apolipoprotein E; CSF tau; dementia; glial fibrillary acidic protein; NFT;
D O I
10.1097/00001756-199712220-00022
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
WE measured tau concentrations in cerebrospinal fluid (CSF) samples taken during the lifetime of 43 patients with Alzheimer's disease (AD) and correlated these values with neurofibrillary tangle (NFT) scores as well as glial fibrillary acidic protein (GFAP) expression as a marker of astrocytosis in the brain post-mortem. The CSF tan values showed a positive correlation with neocortical NET scores (r = 0.44, P < 0.005), while GFAP immunoreactivity did not correlate with CSF tau. This study reveals a high variation in CSF tau Values in patients with neuropathologically confirmed AD (range 194-1539 pg/ml) and indicates that high CSF tau values in the late phase of Alzheimer's disease predict severe neurodegeneration as evidenced by increased NFT scores.
引用
收藏
页码:3961 / 3963
页数:3
相关论文
共 18 条
[1]   TAU IN CEREBROSPINAL-FLUID - A POTENTIAL DIAGNOSTIC MARKER IN ALZHEIMERS-DISEASE [J].
ARAI, H ;
TERAJIMA, M ;
MIURA, L ;
HIGUCHI, S ;
MURAMATSU, T ;
MACHIDA, N ;
SEIKI, H ;
TAKASE, S ;
CLARK, CM ;
LEE, VMY ;
TROJANOWSKI, JQ ;
SASAKI, H .
ANNALS OF NEUROLOGY, 1995, 38 (04) :649-652
[2]   Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology [J].
Arai, H ;
Morikawa, Y ;
Higuchi, M ;
Matsui, T ;
Clark, CM ;
Miura, M ;
Machida, N ;
Lee, VMY ;
Trojanowski, JQ ;
Sasaki, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 236 (02) :262-264
[3]  
Chin SSM, 1996, J NEUROPATH EXP NEUR, V55, P499
[4]   Assessment of CSF levels of tan protein in mildly demented patients with Alzheimer's disease [J].
Galasko, D ;
Clark, C ;
Chang, L ;
Miller, B ;
Green, RC ;
Motter, R ;
Seubert, P .
NEUROLOGY, 1997, 48 (03) :632-635
[5]   Dependence of cerebrospinal fluid Tau protein levels on apolipoprotein E4 allele frequency in patients with Alzheimer's disease [J].
Golombowski, S ;
MullerSpahn, F ;
Romig, H ;
Mendla, K ;
Hock, C .
NEUROSCIENCE LETTERS, 1997, 225 (03) :213-215
[6]   ALZHEIMER PATHOLOGY OF PATIENTS CARRYING APOLIPOPROTEIN-E EPSILON-4 ALLELE [J].
HEINONEN, O ;
LEHTOVIRTA, M ;
SOININEN, H ;
HELISALMI, S ;
MANNERMAA, A ;
SORVARI, H ;
KOSUNEN, O ;
PALJARVI, L ;
RYYNANEN, M ;
RIEKKINEN, PJ .
NEUROBIOLOGY OF AGING, 1995, 16 (04) :505-513
[7]   Tau proteins in cerebrospinal fluid from patients with Alzheimer's disease: A longitudinal study [J].
Isoe, K ;
Urakami, K ;
Shimomura, T ;
Wakutani, Y ;
Ji, Y ;
Adachi, Y ;
Takahashi, K .
DEMENTIA, 1996, 7 (03) :175-176
[8]  
KAYE JA, 1996, ALZ DIS REV, V1, P87
[9]   THE CONSORTIUM TO ESTABLISH A REGISTRY FOR ALZHEIMERS-DISEASE (CERAD) .2. STANDARDIZATION OF THE NEUROPATHOLOGIC ASSESSMENT OF ALZHEIMERS-DISEASE [J].
MIRRA, SS ;
HEYMAN, A ;
MCKEEL, D ;
SUMI, SM ;
CRAIN, BJ ;
BROWNLEE, LM ;
VOGEL, FS ;
HUGHES, JP ;
VANBELLE, G ;
BERG, L .
NEUROLOGY, 1991, 41 (04) :479-486
[10]  
MOLSA PK, 1987, ACTA NEUROL SCAND, V75, P376